Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaoxuan Shao

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Ethnopharmacology|March 6, 2024
Therapeutic potential of traditional Chinese medicine in the prevention and treatment of digestive inflammatory cancer transformation: Portulaca oleracea L. as a promising drugGaoxuan Shao, Ying Liu, Lu Lu, et al.
Journal of Cancer|June 17, 2022
Research progress in the role and mechanism of LPCAT3 in metabolic related diseases and cancerGaoxuan Shao, Yufan Qian, Lu Lu, et al.
Pharmacological Research|June 27, 2026
From Mechanisms to Therapy: Targeting the Gut-Brain Axis in Chronic Gastrointestinal PainXiaofang Chen, Biyu Tan, Gaoxuan Shao, et al.
Journal of Ethnopharmacology|June 6, 2023
Exploring the mechanism of Jianpi Huatan recipe in protecting hepatocellular carcinoma based on network pharmacologyCaiyun Zhang, Hongjiao Xiang, Junmin Wang, et al.
Journal of Pharmaceutical Analysis|June 12, 2025
Huangqin decoction inhibits colorectal inflammatory cancer transformation by improving gut microbiome-mediated metabolic dysfunctionLu Lu, Yuan Li, Hang Su, et al.
Frontiers in Pharmacology|July 25, 2022
The Pathogenesis of HCC Driven by NASH and the Preventive and Therapeutic Effects of Natural ProductsGaoxuan Shao, Ying Liu, Lu Lu, et al.
Journal of Advanced Research|April 8, 2026
LPCAT3 deficiency Drives phospholipid remodeling and mitochondrial oxidative dysfunction to accelerate MASH-HCC developmentGaoxuan Shao, Chenhao Ye, Chenceng Sun, et al.
Life Sciences|May 7, 2026
Targeting the AMPK/ACC pathway with luteolin suppresses de novo lipogenesis and limits tumor burden in a MASH-HCC mouse modelGaoxuan Shao, Chenceng Sun, Chenhao Ye, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Ethnopharmacology|March 6, 2024
Therapeutic potential of traditional Chinese medicine in the prevention and treatment of digestive inflammatory cancer transformation: Portulaca oleracea L. as a promising drugGaoxuan Shao, Ying Liu, Lu Lu, et al.
Journal of Cancer|June 17, 2022
Research progress in the role and mechanism of LPCAT3 in metabolic related diseases and cancerGaoxuan Shao, Yufan Qian, Lu Lu, et al.
Pharmacological Research|June 27, 2026
From Mechanisms to Therapy: Targeting the Gut-Brain Axis in Chronic Gastrointestinal PainXiaofang Chen, Biyu Tan, Gaoxuan Shao, et al.
Journal of Ethnopharmacology|June 6, 2023
Exploring the mechanism of Jianpi Huatan recipe in protecting hepatocellular carcinoma based on network pharmacologyCaiyun Zhang, Hongjiao Xiang, Junmin Wang, et al.
Journal of Pharmaceutical Analysis|June 12, 2025
Huangqin decoction inhibits colorectal inflammatory cancer transformation by improving gut microbiome-mediated metabolic dysfunctionLu Lu, Yuan Li, Hang Su, et al.
Frontiers in Pharmacology|July 25, 2022
The Pathogenesis of HCC Driven by NASH and the Preventive and Therapeutic Effects of Natural ProductsGaoxuan Shao, Ying Liu, Lu Lu, et al.
Journal of Advanced Research|April 8, 2026
LPCAT3 deficiency Drives phospholipid remodeling and mitochondrial oxidative dysfunction to accelerate MASH-HCC developmentGaoxuan Shao, Chenhao Ye, Chenceng Sun, et al.
Life Sciences|May 7, 2026
Targeting the AMPK/ACC pathway with luteolin suppresses de novo lipogenesis and limits tumor burden in a MASH-HCC mouse modelGaoxuan Shao, Chenceng Sun, Chenhao Ye, et al.
Pageof 1